MYUNGMOON Pharm co.,Ltd
KSC: 017180.KS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Korea Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Cheol-han Bae
- Employees
- 282
- Headquarters
- Seoul, South Korea
- IPO year
- 2008
- Market cap
- ₩57B
- Website
- https://www.mmpharm.co.kr
Loading 017180…
Loading profile data…Frequently asked questions about 017180
What does MYUNGMOON Pharm co.,Ltd (017180.KS) do?
MYUNGMOON Pharm co.,Ltd engages in the research, development, production, distribution, and sale of pharmaceuticals in South Korea and internationally. It offers prescription drugs, including anti osteoarthritis, anti-inflammatory analgesics, antiphlogistic enzymes, muscle relaxant, anti rheumarthritis, antibiotics and antifungal, respiratory ag...
Where does 017180.KS trade?
MYUNGMOON Pharm co.,Ltd (017180.KS) trades on the Korea Exchange.
What sector is 017180.KS in?
MYUNGMOON Pharm co.,Ltd (017180.KS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of MYUNGMOON Pharm co.,Ltd?
Cheol-han Bae is the chief executive officer of MYUNGMOON Pharm co.,Ltd (017180.KS).
Where is MYUNGMOON Pharm co.,Ltd headquartered?
MYUNGMOON Pharm co.,Ltd is headquartered in South Korea.
Does 017180.KS pay a dividend?
MYUNGMOON Pharm co.,Ltd (017180.KS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 017180.KS go public?
MYUNGMOON Pharm co.,Ltd (017180.KS) completed its initial public offering in 2008.